Observational studyBMJ open2016

Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study).

Robert M Niven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.